Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Vaccine and Stimulus Optimism Lifts Market Sentiment

By JFD TeamMarket OverviewDec 02, 2020 03:26AM ET
www.investing.com/analysis/vaccine-and-stimulus-optimism-lifts-market-sentiment-200546550
Vaccine and Stimulus Optimism Lifts Market Sentiment
By JFD Team   |  Dec 02, 2020 03:26AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Equities rose, while the US Dollar and the Japanese yen slid on Tuesday, as investors turned their attention back to developments surrounding a potential COVID-19 vaccine. What may have also lifted sentiment is the testimony of Fed Chief Powell and Treasury Secretary Mnuchin, where the two officials agreed on more support for small businesses. On top of that, a group of US Congress members proposed a virus relief package in a bid to pass it sometime this month.

Equities Gain, USD Slides On Vaccine And Stimulus Hopes

The US dollar traded lower against all but two of the other G10 currencies on Tuesday and during the Asian session Wednesday. It lost the most ground against EUR, SEK, and CHF in that order, while it was found virtually unchanged versus AUD and JPY.

USD performance G10 currencies
USD performance G10 currencies

The weakening of the US dollar and the Japanese yen suggests that financial markets traded in a risk-on fashion. However, the strengthening of the Swiss franc and the weakening of the Aussie point otherwise. Thus, in order to get a clearer picture with regards to the broader market sentiment, we prefer to turn our gaze to the equity world. There, major EU and US indices were a sea of green, with the S&P 500 and NASDAQ hitting fresh record highs. That said, investors’ morale softened during the Asian session today. Although South Korea’s KOSPI gained 1.58%, Japan’s Nikkei 225, China’s Shanghai Composite and Hong Kong’s Hang Seng traded virtually unchanged.
Major global stock indices performance
Major global stock indices performance

It seems that following Monday’s profit taking and portfolio rebalancing, market participants turned their attention back to the positive developments over a potential coronavirus drug. Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have already sought emergency approval from the European regulator of their vaccine candidate, while Moderna (NASDAQ:MRNA) announced that it would also ask for conditional approval.

Apart from vaccine hopes, what may have also fueled market sentiment is the testimony of Fed Chair Powell and Treasury Secretary Steven Mnuchin before the Senate Banking Committee. Both officials agreed to provide more help for small businesses as the economic relief following the distribution of a vaccine may not arrive in time to keep them from failing. Although Democrats said that Mnuchin’s decision to shut Fed’s emergency lending programs seemed to contradict his call for help, Powell agreed that at this point businesses may need outright grants from the government, instead of piling on more debt. He also agreed that a separate Treasury fund could be used by the incoming administration of President-elect Joe Biden to re-establish the Fed lending programs if they are needed.

On top of that, Mnuchin held talks with House Speaker Nancy Pelosi over a potential fiscal aid, while a bipartisan group of senators and House members proposed a USD 908bn worth of coronavirus relief package, in a bid to pass a bill sometime this month. US Senate leader Mitch McConnell also raised the importance of including a fresh wave of coronavirus stimulus in a must-pass spending bill aimed at avoiding a government shutdown in the midst of the pandemic.

All this are in line with our view. Remember that yesterday, despite Monday’s setback in equities, we remained positive over the broader market sentiment. We based our view on the positive developments surrounding a potential coronavirus vaccine, while headlines pointing to more fiscal and monetary policy support add more credence. We stick to our guns that equities and other risk-linked assets are likely to continue marching north, while safe-havens, the likes of the US dollar and the Japanese yen, could stay under selling interest.

Euro Stoxx 50 Technical Outlook

Euro Stoxx 50 continues to balance above a short-term upside support line taken from the low of Nov. 9, but at the same time it struggles to overcome the 3538 resistance barrier, which is the highest point of November. For now, we will take a somewhat positive approach, because in order to get comfortable with the upside idea, we need to see a push above the 3538 zone first.

If, eventually, the index does move and stay above that 3538 zone, this will confirm a forthcoming higher high, possibly clearing the path to some higher resistance areas, where one of those could be at 3597. That hurdle is marked by the high of Feb. 26. That said, if the buyers see that hurdle only as a temporary obstacle on the way higher, its break might open the door for a push to the 3676 level, marked by the high of Feb. 25

Alternatively, if the aforementioned upside line breaks and the price falls below the low of Nov. 30, at 3476, that could attract a few more sellers into the game. Euro Stoxx 50 might then drift to the 3438 zone, a break of which may set the stage for a test of the 3395 and 3380 levels. Those levels are marked by the low of Nov. 12 and an intraday swing low of Nov. 9 respectively.

Euro Stoxx 4-hour chart technical analysis
Euro Stoxx 4-hour chart technical analysis

GBP/USD Technical Outlook

Yesterday, we finally saw GBP/USD breaking and staying above the psychological 1.3400 area. This move could be seen as a positive one, as it increases the pair’s chances for a further move north and more buyers may join in if the rate will remain above that 1.3400 zone. For now, we will take a positive approach.

This morning we are seeing a small correction lower, however, if the pair stays above that 1.3400 area, the buyers could step in and drive GBP/USD to the next potential resistance hurdle, at 1.3482. That hurdle is marked by the highest point of September, which might temporarily halt the upmove. That said, if the buyers are still feeling a bit more comfortable than the bears, a break of that 1.3482 zone may lead GBP/USD to the 1.3514 level, marked by the highest point of December 2019.

In order to consider a short-term bearish reversal, we would prefer to wait for a violation of a short-term upside support line drawn from the low of Nov. 13 and then a drop below the 1.3288 hurdle, marked by the low of Nov. 27. All that could strengthen the bearish case and send the pair further south. It might then drift below the 1.3263 obstacle and target the 1.3195 zone, marked by the low of Nov. 19, which coincides with the 200 EMA on our 4-hour chart. GBP/USD may even rebound somewhat, however, if the pair stays somewhere below the 1.3288 barrier, another slide might be possible. If this time GBP/USD is able to move below the 1.3195 hurdle, the next obstacle on the way lower could be at 1.3165, a break of which may clear the way towards the 1.3106 level, marked by the low of Nov. 12.

GBP/USD 4-hour chart technical analysis
GBP/USD 4-hour chart technical analysis

As For Today's Events

In the US, besides the second round of Powell’s and Mnuchin’s testimony, we also have the ADP employment report for November. The private sector is forecast to have gained 400k jobs, after adding 365k in October. This could raise speculation that the NFP print, due out on Friday, may also exceed October’s number, which was at 638k. That said, as we noted several times in the past, the ADP print is far from a reliable predictor of where the NFPs may come in. Even last month, when the ADP slowed to around half (to 365k from 749k), NFPs stayed close to their September figure (638k vs 672k).

The EIA weekly report on crude oil inventories is due to be released as well, with the forecast pointing to a 2.358mn barrels fall after a 0.754mn slide the week before. That said, bearing in mind that the API report revealed a 4.146mn barrels increase, we would consider the risks surrounding the EIA report as tilted to the upside. In any case, this week, oil traders are likely to keep their gaze locked on the outcome of the OPEC+ meeting, where members will decide whether to increase production, or extend the existing curbs.

As for the speakers, apart from Powell and Mnuchin, we have four more on the agenda. Those are Fed Board Governor Randal Quarles, New York Fed President John Williams, ECB Chief Economist Philip Lane, and BoE MPC member Jonathan Haskel.

Vaccine and Stimulus Optimism Lifts Market Sentiment
 

Related Articles

Jeffrey Halley
Variable Side Effects By Jeffrey Halley - Jun 18, 2021

The response by the markets to the FOMC dot plot shock has been variable, to say the least, and not a little surprising to me. Equities did their duty and eased, but not,...

Vaccine and Stimulus Optimism Lifts Market Sentiment

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: The content we produce does not constitute investment advice or investment recommendation (should not be considered as such) and does not in any way constitute an invitation to acquire any financial instrument or product. The Group of Companies of JFD, its affiliates, agents, directors, officers or employees are not liable for any damages that may be caused by individual comments or statements by JFD analysts and assumes no liability with respect to the completeness and correctness of the content presented. The investor is solely responsible for the risk of his investment decisions. Accordingly, you should seek, if you consider appropriate, relevant independent professional advice on the investment considered. The analyses and comments presented do not include any consideration of your personal investment objectives, financial circumstances or needs. The content has not been prepared in accordance with the legal requirements for financial analyses and must therefore be viewed by the reader as marketing information. JFD prohibits the duplication or publication without explicit approval. 75.05% of the retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money. Please read the full Risk Disclosure - https://www.jfdbrokers.com/en/legal/risk-disclosure .
Continue with Google
or
Sign up with Email